In the United States, more than half of people living with HIV are now age 50 and older, which is a testament to the success of advancements such as antiretrovirals and preexposure anaphylaxis.

The EMERALD trial investigators randomly assigned 478 patients with ER+, HER2- advanced breast cancer on a 1:1 basis to receive elacestrant or physician’s choice of standard therapy, which was defined ...

Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...

HPV vaccine remains effective in preventing infections and related cancers, even with incomplete dosing, 17 years after its ...

Specialty drugs, especially biologics, will constitute a significant portion of global drug spending by 2029, driven by cancer care costs. Autoimmune diseases and multiple sclerosis are key short-term ...

An expert discusses the critical need for a holistic, multidisciplinary approach to prevent and manage interconnected ...

Among chemotherapy-naive patients, elacestrant extended median progression-free survival compared with standard therapy, ...

AI models outperform traditional rule-based systems in identifying high-risk patients by integrating diverse data sources and ...

They found that the automated diabetes GLP-1 prior authorization proportion of all diabetes GLP-1 claims grew by 17.5 percentage points, or 39.6%, from October 2024 to July 2025.

Dry eye treatments include over-the-counter eye drops and prescription medicines. The AMCP abstract included immunomodulators ...

In the VALOR trial, brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared ...

Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a ...